153 related articles for article (PubMed ID: 29574274)
1. Pharmacokinetics of radiolabeled dimeric sdAbs constructs targeting human CD20.
Krasniqi A; Bialkowska M; Xavier C; Van der Jeught K; Muyldermans S; Devoogdt N; D'Huyvetter M
N Biotechnol; 2018 Oct; 45():69-79. PubMed ID: 29574274
[TBL] [Abstract][Full Text] [Related]
2. Theranostic Radiolabeled Anti-CD20 sdAb for Targeted Radionuclide Therapy of Non-Hodgkin Lymphoma.
Krasniqi A; D'Huyvetter M; Xavier C; Van der Jeught K; Muyldermans S; Van Der Heyden J; Lahoutte T; Tavernier J; Devoogdt N
Mol Cancer Ther; 2017 Dec; 16(12):2828-2839. PubMed ID: 29054987
[TBL] [Abstract][Full Text] [Related]
3. Improved tumor targeting of anti-epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology.
Tijink BM; Laeremans T; Budde M; Stigter-van Walsum M; Dreier T; de Haard HJ; Leemans CR; van Dongen GA
Mol Cancer Ther; 2008 Aug; 7(8):2288-97. PubMed ID: 18723476
[TBL] [Abstract][Full Text] [Related]
4. PET Imaging of Macrophage Mannose Receptor-Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody Fragments.
Blykers A; Schoonooghe S; Xavier C; D'hoe K; Laoui D; D'Huyvetter M; Vaneycken I; Cleeren F; Bormans G; Heemskerk J; Raes G; De Baetselier P; Lahoutte T; Devoogdt N; Van Ginderachter JA; Caveliers V
J Nucl Med; 2015 Aug; 56(8):1265-71. PubMed ID: 26069306
[TBL] [Abstract][Full Text] [Related]
5. High contrast tumor imaging with radio-labeled antibody Fab fragments tailored for optimized pharmacokinetics via PASylation.
Mendler CT; Friedrich L; Laitinen I; Schlapschy M; Schwaiger M; Wester HJ; Skerra A
MAbs; 2015; 7(1):96-109. PubMed ID: 25484039
[TBL] [Abstract][Full Text] [Related]
6. A non-internalised CD38-binding radiolabelled single-domain antibody fragment to monitor and treat multiple myeloma.
Duray E; Lejeune M; Baron F; Beguin Y; Devoogdt N; Krasniqi A; Lauwers Y; Zhao YJ; D'Huyvetter M; Dumoulin M; Caers J
J Hematol Oncol; 2021 Nov; 14(1):183. PubMed ID: 34727950
[TBL] [Abstract][Full Text] [Related]
7. Site-specific labeling of cysteine-tagged camelid single-domain antibody-fragments for use in molecular imaging.
Massa S; Xavier C; De Vos J; Caveliers V; Lahoutte T; Muyldermans S; Devoogdt N
Bioconjug Chem; 2014 May; 25(5):979-88. PubMed ID: 24815083
[TBL] [Abstract][Full Text] [Related]
8. Radionuclide therapy of HER2-positive microxenografts using a 177Lu-labeled HER2-specific Affibody molecule.
Tolmachev V; Orlova A; Pehrson R; Galli J; Baastrup B; Andersson K; Sandström M; Rosik D; Carlsson J; Lundqvist H; Wennborg A; Nilsson FY
Cancer Res; 2007 Mar; 67(6):2773-82. PubMed ID: 17363599
[TBL] [Abstract][Full Text] [Related]
9. Targeted Radionuclide Therapy with Low and High-Dose Lutetium-177-Labeled Single Domain Antibodies Induces Distinct Immune Signatures in a Mouse Melanoma Model.
Ertveldt T; De Beck L; De Ridder K; Locy H; de Mey W; Goyvaerts C; Lecocq Q; Ceuppens H; De Vlaeminck Y; Awad RM; Keyaerts M; Devoogdt N; D'Huyvetter M; Breckpot K; Krasniqi A
Mol Cancer Ther; 2022 Jul; 21(7):1136-1148. PubMed ID: 35499391
[TBL] [Abstract][Full Text] [Related]
10. Selection and characterization of single domain antibodies against human CD20.
Liu JL; Zabetakis D; Goldman ER; Anderson GP
Mol Immunol; 2016 Oct; 78():146-154. PubMed ID: 27639717
[TBL] [Abstract][Full Text] [Related]
11. [(177)Lu]pertuzumab: experimental studies on targeting of HER-2 positive tumour cells.
Persson M; Tolmachev V; Andersson K; Gedda L; Sandström M; Carlsson J
Eur J Nucl Med Mol Imaging; 2005 Dec; 32(12):1457-62. PubMed ID: 16193312
[TBL] [Abstract][Full Text] [Related]
12. Site-specific radiometal labeling and improved biodistribution using ABY-027, a novel HER2-targeting affibody molecule-albumin-binding domain fusion protein.
Orlova A; Jonsson A; Rosik D; Lundqvist H; Lindborg M; Abrahmsen L; Ekblad C; Frejd FY; Tolmachev V
J Nucl Med; 2013 Jun; 54(6):961-8. PubMed ID: 23528382
[TBL] [Abstract][Full Text] [Related]
13. A systematic study on the utility of CHX-A''-DTPA-NCS and NOTA-NCS as bifunctional chelators for
Pandey U; Gamre N; Lohar SP; Dash A
Appl Radiat Isot; 2017 Sep; 127():1-6. PubMed ID: 28478331
[TBL] [Abstract][Full Text] [Related]
14. Development of 177Lu-nanobodies for radioimmunotherapy of HER2-positive breast cancer: evaluation of different bifunctional chelators.
D'Huyvetter M; Aerts A; Xavier C; Vaneycken I; Devoogdt N; Gijs M; Impens N; Baatout S; Ponsard B; Muyldermans S; Caveliers V; Lahoutte T
Contrast Media Mol Imaging; 2012; 7(2):254-64. PubMed ID: 22434639
[TBL] [Abstract][Full Text] [Related]
15. Preclinical Evaluation of a Radiotheranostic Single-Domain Antibody Against Fibroblast Activation Protein α.
Dekempeneer Y; Massa S; Santens F; Navarro L; Berdal M; Lucero MM; Pombo Antunes AR; Lahoutte T; Van Ginderachter JA; Devoogdt N; D'Huyvetter M
J Nucl Med; 2023 Dec; 64(12):1941-1948. PubMed ID: 38040444
[TBL] [Abstract][Full Text] [Related]
16. ⁹⁹mTc-labeled single-domain antibody EG2 in targeting epidermal growth factor receptor: an in-vitro and mouse model in-vivo study.
Li C; Wen B; Wang L; Feng H; Xia X; Ding Z; Gao B; Zhang Y; Lan X
Nucl Med Commun; 2015 May; 36(5):452-60. PubMed ID: 25591074
[TBL] [Abstract][Full Text] [Related]
17. Tumor Uptake of Anti-CD20 Fabs Depends on Tumor Perfusion.
Mendler CT; Feuchtinger A; Heid I; Aichler M; D'Alessandria C; Pirsig S; Blechert B; Wester HJ; Braren R; Walch A; Skerra A; Schwaiger M
J Nucl Med; 2016 Dec; 57(12):1971-1977. PubMed ID: 27417649
[TBL] [Abstract][Full Text] [Related]
18. High treatment efficacy by dual targeting of Burkitt's lymphoma xenografted mice with a (177)Lu-based CD22-specific radioimmunoconjugate and rituximab.
Weber T; Bötticher B; Mier W; Sauter M; Krämer S; Leotta K; Keller A; Schlegelmilch A; Grosse-Hovest L; Jäger D; Haberkorn U; Arndt MA; Krauss J
Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):489-98. PubMed ID: 26341366
[TBL] [Abstract][Full Text] [Related]
19. Serum immunoglobulin or albumin binding single-domain antibodies that enable tailored half-life extension of biologics in multiple animal species.
Harmsen MM; Ackerschott B; de Smit H
Front Immunol; 2024; 15():1346328. PubMed ID: 38352869
[TBL] [Abstract][Full Text] [Related]
20. A Novel ¹¹¹In-Labeled Anti-Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate Cancer.
Chatalic KL; Veldhoven-Zweistra J; Bolkestein M; Hoeben S; Koning GA; Boerman OC; de Jong M; van Weerden WM
J Nucl Med; 2015 Jul; 56(7):1094-9. PubMed ID: 25977460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
